Company
CanadaRubicon Research Canada Limited, Concord, Canada – FDA Inspections
Inspection records and compliance data for Rubicon Research Canada Limited in Concord. 4 FDA inspections on record, last inspected April 24, 2026.
Company Profile
This profile covers Rubicon Research Canada Limited based in Concord, Canada.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 27, 2016. Last inspected April 24, 2026.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2026 | Not classified | Human Drugs | 1319538 |
| November 3, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1224373 |
| October 18, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1073583 |
| July 27, 2016 | VAI | Human Drugs · Drug Quality Assurance | 981956 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 1 inspection · last September 24, 2024
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Rubicon Research Canada Limited
FEI Number
3003285511
Address
255 Spinnaker Way Unit 6, Concord, Canada
Country
Canada
ID: 807792a8-f94f-4118-8583-a18125ce41f8